胰高血糖素样肽1受体
胰高血糖素
兴奋剂
双盲
安慰剂
胰高血糖素受体
随机对照试验
安慰剂对照研究
医学
胰高血糖素样肽-1
内科学
内分泌学
受体
胰岛素
糖尿病
2型糖尿病
病理
替代医学
作者
Stephen A. Harrison,Sarah Browne,John J. Suschak,Shaheen Tomah,Julio Gutiérrez,Jay Yang,Mary Roberts,M. Scott Harris
标识
DOI:10.1016/j.jhep.2024.07.006
摘要
This was a randomized, double-blind, placebo-controlled study to assess the effects of pemvidutide, a glucagon-like peptide-1 (GLP-1)/glucagon dual receptor agonist, on liver fat content (LFC) in subjects with metabolic dysfunction-associated steatotic liver disease (MASLD).
科研通智能强力驱动
Strongly Powered by AbleSci AI